tirzepatide gray Real-World Use of GLP-1s Yields Less Weight Loss Than Clinical Trials Tirzepatide 2.5mg: Weight Loss Starter

Regulation of satellite cell function in sarcopenia

Sural nerve pathology in diabetic patients with minimal but progressive neuropathy

Studies consistently show that approximately 30 to 40% of weight lost on GLP-1 agonists comes from lean tissue, primarily muscle

doi:10.3390/biomedicines13051049 Karagiannis, T., Malandris, K., Avgerinos, I., Stamati, A., Kakotrichi, P., Liakos, A., Vasilakou, D., Kakaletsis, N., Tsapas, A., & Bekiari, E

Since muscle is a major energy utilizer 17,41 , minimizing muscle mass during caloric restriction can substantially reduce energy expenditure, thus sparing energy for the maintenance of other more critical organ systems 42,43,44

Important Safety & Handling Information This product is intended for laboratory research use only